Previous 10 | Next 10 |
Masimo SpHb Demonstrated “Clinically Acceptable Accuracy” of Hemoglobin Measurement, Even at Low Hemoglobin Levels Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the Egyptian Journal of Anesthesia in which Dr. Mohamed Ibrahim...
Summary Fundsmith’s 13F portfolio value decreased from $23.45B to $21.07B this quarter. They added Otis Worldwide while decreasing Intuit and PayPal Holdings. The top three positions are Microsoft, Philip Morris International, and Estee Lauder, and they add up to ~23% of the ...
Breakthrough Ecosystem Expansion to Seamlessly Integrate Continuous Health Data from Masimo Devices with Four Million HEOS-Enabled Devices Launches Masimo (NASDAQ: MASI) today announced the launch of the expansion of the HEOS platform to provide a robust and always-on connection t...
Masimo’s Technological Capabilities, Track Record of Innovation and Customer-Driven Approach to Product Development Fueling Continued Growth and Entry into New Markets Masimo Corporation (Nasdaq: MASI) (“Masimo” or the “Company”) will host its Investor...
Breakthrough Early Warning Solution, for Integration with Masimo Patient SafetyNet™, Is Designed to Help Clinicians Catch Deterioration in Patient Condition Masimo (NASDAQ: MASI) today announced the limited market release of Sepsis Index (Si™), an early warning indicat...
Masimo (NASDAQ: MASI) today announced the full market release of Hydration Index (Hi™) for the Masimo W1™ watch. The Masimo W1, an advanced health tracking wearable, is the first watch to offer accurate, continuous pulse oximetry measurements and insightful health data, from the l...
Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized, controlled trial published in the Journal of the College of Physicians and Surgeons Pakistan . In the study, Dr. Sukriye Akdag and colleagues at Marmara University in Istanbul, Turkey assessed t...
Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 34 th Annual Healthcare Conference on Wednesday, November 30, 2022 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masim...
Masimo (NASDAQ: MASI) today announced the publication of a peer-reviewed study regarding Masimo SET ® pulse oximetry performance in varying skin pigmentation in the Journal of Clinical Monitoring and Computing. The retrospective trial, “Racial effects on Masimo...
The United States District Court for the Central District of California has ruled that a former Masimo (NASDAQ: MASI) engineer misappropriated trade secrets related to Masimo’s pulse oximetry technology. The former Masimo engineer, Marcelo Lamego, also served as Chief Tec...
News, Short Squeeze, Breakout and More Instantly...
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ: MASI) will release second quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, August 6, 2024. The conference call to review the results will begin at 1...
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any Further Beyond September 19 and Hopefully Is Held Sooner Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Mas...
Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court i...